Author:
Goudar Ranjit K.,Vlahovic Gordana
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Ries LA, Melbert D, Krapcho M, et al.: (2007) SEER Cancer Statistics Review, 1975–2004. Bethesda: National Cancer Institute; 2007. http://seer.cancer.gov/csr/1975_2004/ .
2. Herbst RS, O’Neill VJ, Fehrenbacher L, et al.: Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer. J Clin Oncol 2007, 25:4743–4750.
3. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27–31.
4. Stinchcombe TE, Socinski MA: Bevacizumab in the treatment of non-small-cell lung cancer. Oncogene 2007, 26:3691–3698.
5. Thomlinson RH, Gray LH: The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955, 9:539–549.
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献